Project 170364

Understanding the role of the mitochondrial rhomboid protease in membrane dynamics

170364

Understanding the role of the mitochondrial rhomboid protease in membrane dynamics

$690,225
Project Information
Study Type: Trial Randomized_Controlled_Trial
Therapeutic Area: Infectious_Disease
Research Theme: Biomedical
Disease Area: meningococcal disease prevention
Data Type: Canadian
Institution & Funding
Principal Investigator(s): Mcquibban, George A
Institution: University of Toronto
CIHR Institute: Genetics
Program: Operating Grant
Peer Review Committee: Cell Biology & Mechanisms of Disease
Competition Year: 2008
Term: 5 yrs 0 mth
Abstract Summary

Mitochondria are extremely dynamic organelles undergoing constant double membrane fusion and fission reactions. The control and mechanisms involved to regulate this activity are currently of great interest in both the health and the death of the cell. We have discovered the key action of the mitochondrial rhomboid protease in regulating membrane fusion. Rhomboids are highly conserved intramembrane proteases that process initially membrane tethered substrates. We have now identified three important substrates for the mitochondrial rhomboid: Mgm/OPA; a dynamin-related protein, Omi/HtrA2; a mitochondrial targeted protease, and Pink1; a mitochondrial targeted kinase. The rhomboid-dependent processing of these three proteins is required for their biological activities. Mutations in OPA cause the most prevalent early onset blindness mitochondrial disease called dominant optic atrophy; and both Pink1 and Omi have been linked to Parkinson's disease, underscoring the relevance of these discoveries. By undertaking a series of in vitro structure/function analyses, combined with in vivo assays in both yeast and flies, we hope to uncover the significance of the rhomboid cleavage event, and understand its relevance to mitochondrial function in human disease.

Research Characteristics

This project includes the following research characteristics:

Cost Effectiveness
Budget Impact
Health Technology Assessment
Resource Utilization
Implementation Science
Policy Evaluation
Health System Integration
Scalability Assessment
Barrier Identification
Real World Evidence
Patient Engagement
Regulatory Pathway
Ethics Focus
Data Sharing
Health Equity
Cohort Establishment
Multicenter
Knowledge Translation Focus
Equity Considerations
Safety Focus
Biomarker Endpoints
Time to Event
Vulnerable Populations
Dose Response
Study Justification

"evaluate the effectiveness of meningococcal C conjugate vaccine programs in Canadian children"

Novelty Statement

"first study to compare effectiveness of different dosing schedules (1, 2, or 3 doses) of meningococcal vaccines"

Methodology Innovation

comparison of different provincial vaccination schedules

Keywords
Dominant Optic Atrophy Drosophila Genetics Membrane Dynamics Mitochondria Yeast